Evidence suggests that levobupivacaine has similar pharmacodynamic properties to racemic bupivacaine. We sought to investigate whether this similarity extends to opioid sparing when levobupivacaine is used for epidural analgesia in laboring women by quantifying the effect of fentanyl on the minimum local analgesic concentration (MLAC) of levobupivacaine. Onehundred-six women requesting epidural analgesia for labor pain were recruited in this randomized, doubleblinded, up-down sequential allocation study. Each received 20 mL of one of three test solutions: levobupivacaine control, levobupivacaine and fentanyl 2 g/mL, or levobupivacaine and fentanyl 3 g/mL. The initial levobupivacaine concentration was 0.07% wt/vol in each group, with subsequent concentrations of levobupivacaine being determined by the response of the previous patient (testing interval 0.01% wt/vol). Efficacy was accepted if the visual analog score decreased to 10 mm or less on a 100-mm scale within 30 min. The MLAC of levobupivacaine in the control group was 0.091% wt/vol (95% CI, 0.052-0.130). Fentanyl at concentrations of 2 g/mL and 3 g/mL significantly reduced the MLAC of levobupivacaine to 0.047% wt/ vol (95% CI, 0.023-0.072) and 0.050% wt/vol (95% CI, 0.035-0.065), respectively (P Ͻ 0.001). A dosedependent effect was not demonstrated. We conclude that fentanyl significantly reduces levobupivacaine requirements for epidural analgesia in labor. E pidural bupivacaine is widely used in obstetric anesthesia to provide analgesia for labor and delivery. Concerns about excessive motor block with bupivacaine have led to strategies to reduce the risk of this unwanted side effect. The concentration of local anesthetic used for epidural analgesia can be reduced by the addition of epidural opioid. This local anesthetic-sparing effect has been demonstrated for bupivacaine with fentanyl (1) and sufentanil (2). Both studies used the minimum local analgesia concentration (MLAC) model and demonstrated the opioid effect to be dose dependent.
Evidence suggests that levobupivacaine has similar pharmacodynamic properties to racemic bupivacaine. We sought to investigate whether this similarity extends to opioid sparing when levobupivacaine is used for epidural analgesia in laboring women by quantifying the effect of fentanyl on the minimum local analgesic concentration (MLAC) of levobupivacaine. Onehundred-six women requesting epidural analgesia for labor pain were recruited in this randomized, doubleblinded, up-down sequential allocation study. Each received 20 mL of one of three test solutions: levobupivacaine control, levobupivacaine and fentanyl 2 g/mL, or levobupivacaine and fentanyl 3 g/mL. The initial levobupivacaine concentration was 0.07% wt/vol in each group, with subsequent concentrations of levobupivacaine being determined by the response of the previous patient (testing interval 0.01% wt/vol). Efficacy was accepted if the visual analog score decreased to 10 mm or less on a 100-mm scale within 30 min. The MLAC of levobupivacaine in the control group was 0.091% wt/vol (95% CI, 0.052-0.130). Fentanyl at concentrations of 2 g/mL and 3 g/mL significantly reduced the MLAC of levobupivacaine to 0.047% wt/ vol (95% CI, 0.023-0.072) and 0.050% wt/vol (95% CI, 0.035-0.065), respectively (P Ͻ 0.001). A dosedependent effect was not demonstrated. We conclude that fentanyl significantly reduces levobupivacaine requirements for epidural analgesia in labor. E pidural bupivacaine is widely used in obstetric anesthesia to provide analgesia for labor and delivery. Concerns about excessive motor block with bupivacaine have led to strategies to reduce the risk of this unwanted side effect. The concentration of local anesthetic used for epidural analgesia can be reduced by the addition of epidural opioid. This local anesthetic-sparing effect has been demonstrated for bupivacaine with fentanyl (1) and sufentanil (2) . Both studies used the minimum local analgesia concentration (MLAC) model and demonstrated the opioid effect to be dose dependent.
Racemic bupivacaine is a mixture of two optical isomers. Levobupivacaine is the S(-) enantiomer of bupivacaine, and animal studies suggest that it may have reduced cardiac and central nervous toxicity when compared with racemic bupivacaine (3, 4) . We have demonstrated previously, by using the MLAC model, that levobupivacaine and racemic bupivacaine are of similar potency (2% potency difference between commercial preparations) (5). Burke et al. (6) compared 0.25% levobupivacaine with 0.25% bupivacaine in laboring women and found no difference in the onset, spread, and duration of analgesia. It is also likely that the sparing effect of opioids in combination with levobupivacaine will be similar in nature and magnitude to that seen with racemic bupivacaine. We wished to test this hypothesis by investigating the effect of fentanyl on the MLAC of levobupivacaine in laboring women.
Methods
The study was conducted at St. James's University Hospital, Leeds, UK, after approval by the hospital ethics committee. After obtaining written informed consent, we enrolled women requesting epidural pain relief for the first stage of labor in this randomized, double-blinded, parallel group, up-down sequential allocation study. All women had reached at least 36 wk gestation in singleton pregnancies with cephalic fetal presentation. They were of ASA physical status I or II and had initial pain scores more than 30 mm on a 100-mm visual analog scale, where 0 represented no pain and 100 the worst possible pain. We excluded women in whom cervical dilation exceeded 5 cm and those who had received opioid or sedative medication.
Epidural blocks were sited in a standard manner. An IV infusion of 0.9% saline was commenced through a forearm cannula. With the woman in the sitting position, the epidural space was found by using loss of resistance to saline at either L2-3 or L3-4. The volume of saline was restricted to 2 mL to minimize dilution of subsequent injections. A 20-gauge catheter was inserted 3 cm into the epidural space. For the purposes of this study, a lidocaine test dose was not used.
Women were allocated randomly to one of three groups by using computer generated random numbers. A 20-mL bolus of test solution was administered through the epidural catheter over 5 min. Women in the Levobupivacaine Control Group received 20 mL of levobupivacaine hydrochloride (Chirocaine; Chiroscience Ltd, Cambridge, UK). Women in the Fentanyl Groups received 20 mL of levobupivacaine with fentanyl 2 g/mL or 20 mL of levobupivacaine with fentanyl 3 g/mL. The initial levobupivacaine concentration in each group was 0.07%. The concentration of levobupivacaine for subsequent patients in each group was determined by the outcome in the previous patient according to the technique of up-down sequential allocation. Solutions were freshly prepared with 0.9% saline as diluent to give the required concentration at room temperature.
An observer blinded to both fentanyl and levobupivacaine concentrations assessed the efficacy of the test solution by use of the 100-mm visual analog scale. Assessments were made at 5-min intervals until subjects scored 10 mm or less. Three outcomes were possible:
1. Effective: A concentration was considered effective if the woman indicated a visual analog pain score of 10 mm or less during contractions within 30 min of injection. After an effective outcome, the concentration of levobupivacaine for the next woman in that group was decreased by the testing interval of 0.01%. 2. Ineffective: A concentration was considered ineffective when a pain score of more than 10 mm recorded 30 min after injection decreased to 10 mm or less within 30 min of the administration of an epidural rescue injection of 15 mL of 0.25% bupivacaine (Marcain; Astra, Kings Langley, UK). After an ineffective outcome, the concentration of levobupivacaine for the next woman in that group was increased by 0.01%. 3. Repeat: This outcome was recorded for women with a pain score of more than 10 mm at 30 min that remained more than 10 mm, 30 min after the rescue injection. After a repeat outcome, the concentration of levobupivacaine was repeated for the next woman in that group. Data collected at 5-min intervals until efficacy was achieved included maternal blood pressure and heart rate and fetal heart rate.
Patient characteristics and obstetric data were collected and are presented as means (sd), medians (interquartile range), and counts, as appropriate. Hemodynamic data are presented as mean (sd) and were analyzed with analysis of variance. The median effective concentration for each group was estimated with the formula of Dixon and Massey (7), which enabled the MLACs with 95% confidence intervals to be derived. The effect of fentanyl was examined by using analysis of variance with Bartlett's test for homogeneity of variance. Further analysis was by the nonparametric Kruksal-Wallis method with Dunn's post hoc tests for multiple comparisons. The following software was used to analyze the data: Excel 97 (Microsoft Corporation, Redmond, WA), Statistical Package for the Social Sciences 7.5 for Windows (SPSS Inc, Chicago, IL), and GraphPad Instat 3.01 (GraphPad Software, San Diego, CA). Statistical significance was defined for overall ␣ errors at the 0.05 level.
Sample size was estimated for a one-way analysis of variance design, ␣ error of 0.05, and power at 0.8 to detect an effect size of 0.5, assuming a between-group sd at 0.02 (1) and a within-group sd at 0.04 (6) . This required a minimum of 28 patients in each group.
Results
Of the 106 women enrolled in the study, 8 had "repeat" outcomes denoting technical failure of the epidural and 8 were withdrawn because of protocol violations (Table 1) . Of the protocol violations, one women was found to be below the age of consent, four had received an opioid before enrollment, two delivered, and one received further opioids before an outcome was reached. The patient characteristics and obstetric data of the 90 women included in the study were similar in the three groups (Table 2 ). There were no significant differences in hemodynamic variables among the groups (Table 3) . Two women receiving levobupivacaine with 2 g/mL fentanyl experienced hypotension, during which the systolic arterial blood pressure decreased by more than 20% of baseline to Ͻ100 mm Hg. One of these episodes was associated 127 (9) 126 (9) 125 (15) Results are expressed as mean (sd). SBP ϭ systolic blood pressure; MHR ϭ maternal heart rate; FHR ϭ fetal heart rate.
with the administration of the epidural rescue dose of 37.5 mg of racemic bupivacaine. Both episodes resolved when the women adopted a lateral position to reduce aortocaval compression. No participants required ephedrine for hypotension, and maternal bradycardia of Ͻ50 bpm was not seen. An episode of transient fetal bradycardia to 105 bpm was recorded in one woman receiving levobupivacaine with 3 g/mL fentanyl. This was associated with the administration of a rescue dose and responded to improved maternal position. Figure 1 shows the distribution of effective and ineffective analgesia in each group. There were significant reductions in the MLAC of levobupivacaine with 2 g/mL and 3 g/mL fentanyl compared with the levobupivacaine control. A dose-dependent effect was not demonstrated (Table 4 ).
Discussion
The use of an up-down sequential allocation study design to estimate the relative potency of epidural anesthetics was first described in 1995 (8) . Since then, it has been used in a number of centers to compare different local anesthetics (5, 9, 10) and the local anesthetic-sparing effect of epidural opioid (1, 2) . The MLAC of levobupivacaine in this study was 0.091% wt/vol (95% CI, 0.052-0.130) and is similar to the only other estimation of the MLAC of levobupivacaine of 0.083% wt/vol (95% CI, 0.065-0.101) (6) . Fentanyl doses of 2 g/mL and 3 g/mL were chosen by using the information from the fentanyl and bupivacaine study, which suggested that an effect would be difficult to detect at 1 g/mL, and that 4 g/mL would be associated with significant pruritus (1) .
Fentanyl significantly reduced the MLAC of levobupivacaine by 48% and 45% at 2 g/mL and 3 g/mL, respectively. The equivalent figures for racemic bupivacaine are 31% and 45% (1). The dosedependent effect of fentanyl seen with racemic bupivacaine was not demonstrated with levobupivacaine. The absence of a dose-dependent effect is likely to be a result of differences in patient and obstetric variables in the groups and variability of response. The variance in the groups in the current study was more than that seen in the fentanyl and racemic bupivacaine study (1) and demonstrated significant heterogeneity (Bartlett's test; P ϭ 0.0041). The increased variability in the current study, coupled with the heterogeneity in variance, would be expected to reduce the likelihood of demonstrating a dose-dependent effect.
We included both nulliparous and multiparous women in this study. Two independent studies to compare the potency of ropivacaine with bupivacaine found similar potency ratios. One group recruited women of mixed parity (9) and the other, nulliparous women (10) . If parity has an effect on the analgesic requirement, it is likely to be related to the rate of cervical dilation or the rate of descent of the presenting fetal part. The study design limits the evaluation period to 30 minutes, which reduces the impact of these factors. Multiple regression analyses of previous MLAC studies suggest that parity itself is not significantly associated with bupivacaine requirements (11) . Nulliparous women, however, have higher initial visual analog scores for a given cervical dilation, in keeping with less efficient uterine contraction and slower descent of the fetal head. Increasing visual analog score at study entry significantly increases the requirement for bupivacaine (11) . In our study, the number of nulliparous women was similar in the two fentanyl groups and therefore unlikely to mask a dose-dependent effect.
MLAC estimates are influenced by cervical dilation. Increasing cervical dilation significantly increases the requirement for racemic bupivacaine (11, 12) . In our study, although the median cervical dilation of 3 cm was the same in both fentanyl groups, the interquartile range of the 3-g/mL group was 3-4 cm, as compared with 2-4 cm with 2 g/mL. This suggests a skew toward higher cervical dilation in the 3-g/mL group that had arisen by chance. The increased analgesic requirement of this group may have been sufficient to mask a dose-dependent effect.
In summary, we have found epidural fentanyl to have a significant, although not dose-dependent, local anesthetic-sparing effect when used with levobupivacaine for epidural analgesia in early labor. 
